close

Login

Library
Shopping Cart
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 
Direct (781) 489-7301,  Toll Free (866) 285-7215

Search

Search
BCC Advance Search
Press Room

Global Demand For Stem Cells To Reach $6.6 Billion In 2016

July 12, 2012
Additional Reports

 

Wellesley, Mass. – According to a new technical market research report, GLOBAL MARKETS FOR STEM CELLS (BIO035D) from BCC Research (www.bccresearch.com), the global market for stem cells was valued at $3.8 billion in 2011 and is projected to reach $6.6 billion in 2016, a five-year compound annual growth rate (CAGR) of 11.7%.

The global market for stem cells can be broken down into four regions: theAmericas, Europe,Asia, and the rest of the world.

TheAmericasaccounted for nearly $1.4 billion in 2011 and the region is expected to reach $2.3 billion in 2016, a CAGR of 11.5% for the five-year period.

Europe, worth $872 million in 2011, is projected to account for nearly $1.5 billion in 2016, a CAGR of 10.9%.

Asia, worth $828 million in 2011, should be valued at nearly $1.5 billion in 2016, a CAGR of 12.5%.

The rest of the world totaled $768 million in 2011 and is expected to experience a 12% CAGR, reaching nearly $1.4 billion by 2016.

Stem cells are the first cells formed when an egg and a sperm join and the resultant zygote begins to divide. They are the precursors of all the different types of cells that make up the body. They are characterized by self-renewal – that is, the capacity to continue dividing to make ever-larger populations of stem cells – and the capacity to differentiate into any mature cell type when they receive appropriate chemical instructions.

The major market for stem cells will be their use in the treatment of disease, and there is already a population of companies specializing in developing stem cells directed toward specific disease targets. This market opportunity is still largely at an early, experimental stage. The main exception is the use of stem cells taken from a patient’s own bone marrow to treat conditions such as leukemia, which is a failure of normal hematopoiesis, or formation of blood cells. This use of stem cells is well established.

This report is designed to satisfy the information needs of a wide variety of individuals involved in the pharmaceutical marketplace, including company senior management executives seeking to base their strategic decisions on the best available information on market forces and trends. It also is aimed, however, at managers and executives in marketing, research, planning, and sales departments who need readable, comprehensive, and up-to-date background on the marketplace in which they are operating.

SUMMARY FIGURE
GLOBAL STEM CELL MARKET AND FORECASTS, 2010-2016
($ MILLIONS)
GLOBAL STEM CELL MARKET AND FORECASTS, 2010-2016
To Contact us, click here  help


Source: BCC Research

Global Markets for Stem Cells( BIO035D )
Publish Date: July 2012    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49 Walnut Park, Building 2, Wellesley, MA 02481, Telephone: 866-285-7215; Email: editor@bccresearch.com as the source and publisher. Thank you.